Lipocine Stock Valuation

LPCN -  USA Stock  

USD 1.17  0.04  3.54%

What is the current enterprise value of Lipocine? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Lipocine, is its stock price multiplied by the total number of shares outstanding, calculating Lipocine's enterprise value requires a different approach. It uses Lipocine's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is expected to rise to about 27.4 M this year, although the value of Free Cash Flow will most likely fall to (16.5 M).
Lipocine secures a last-minute Real Value of $1.79 per share. The latest price of the firm is $1.17. Today, the firm appears to be undervalued. Our model forecasts the value of Lipocine from analyzing the firm fundamentals such as Current Valuation of 67.9 M, return on equity of (77.83) %, and Shares Owned by Insiders of 2.51 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Lipocine Valuation 

Lipocine Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Lipocine's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
27th of November 2021
Please note that Lipocine's price fluctuation is very risky at this time. Calculation of the real value of Lipocine is based on 3 months time horizon. Increasing Lipocine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Lipocine is useful when determining the fair value of the Lipocine stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Lipocine. Since Lipocine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lipocine Stock. However, Lipocine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Lipocine helps investors to forecast how Lipocine stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lipocine more accurately as focusing exclusively on Lipocine's fundamentals will not take into account other important factors:
Estimates (4)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
3 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Lipocine's intrinsic value based on its ongoing forecasts of Lipocine's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Lipocine's closest peers. When choosing an evaluation method for Lipocine, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Lipocine Investments


Lipocine Valuation Drivers Correlation

Many accounts on the financial statements of Lipocine are highly interrelated and sometimes correlated. Consequently, when conducting Lipocine's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Lipocine
Click cells to compare fundamentals

Lipocine Valuation Trend

Knowing Lipocine's actual value is paramount for traders to make sound investment determinations. Lipocine's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Lipocine's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Lipocine's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Lipocine Market Cap

Lipocine is rated second overall in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 312.12 Million. Lipocine totals roughly 96.24 Million in market capitalization claiming about 31% of stocks in Biotechnology industry.
Capitalization  Workforce  Total debt  Revenue  Valuation

Lipocine Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Lipocine's current stock value. Our valuation model uses many indicators to compare Lipocine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lipocine competition to find correlations between indicators driving Lipocine's intrinsic value. More Info.
Lipocine is currently regarded as number one stock in price to earning category among related companies. It is currently regarded as number one stock in price to book category among related companies . The Price to Book Value is projected to slide to 5.02. Comparative valuation analysis is a catch-all model that can be used if you cannot value Lipocine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lipocine's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipocine's earnings, one of the primary drivers of an investment's value.

About Lipocine Valuation

The equity valuation mechanism determines the current worth of Lipocine on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Lipocine. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Lipocine based exclusively on its fundamental and basic technical indicators. By analyzing Lipocine's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Lipocine's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lipocine. We calculate exposure to Lipocine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lipocine's related companies.
Last ReportedProjected for 2021
Gross Profit148.5 K152.4 K
Profit Margin(70.95) (72.82) 
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. The companys pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. Lipocine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Lipocine Quarterly Enterprise Value

89.23 MillionShare

Lipocine Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Lipocine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio5.32
Enterprise Value To Ebitda-4.44

Lipocine Current Valuation Indicators

Valuation refers to the process of determining the present value of Lipocine and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Lipocine we look at many different elements of the entity such as Lipocine's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Lipocine, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Lipocine's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Lipocine's worth.
Additionally, see Stocks Correlation. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.